Hyen Joo Park Selected Research

mezerein

1/2015	Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
11/2012	Anticancer Activity of Novel Daphnane Diterpenoids from Daphne genkwa through Cell-Cycle Arrest and Suppression of Akt/STAT/Src Signalings in Human Lung Cancer Cells.
10/2011	Growth inhibition of human lung cancer cells via down-regulation of epidermal growth factor receptor signaling by yuanhuadine, a daphnane diterpene from Daphne genkwa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyen Joo Park Research Topics

Disease

31	Neoplasms (Cancer) 04/2021 - 06/2003
11	Colonic Neoplasms (Colon Cancer) 09/2020 - 06/2003
8	Inflammation (Inflammations) 01/2022 - 06/2003
8	Neoplasm Metastasis (Metastasis) 04/2021 - 12/2005
8	Colorectal Neoplasms (Colorectal Cancer) 09/2020 - 04/2011
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2020 - 10/2011
6	Carcinogenesis 04/2021 - 06/2003
6	Lung Neoplasms (Lung Cancer) 01/2016 - 09/2003
5	Fibrosarcoma 08/2012 - 12/2005
2	Edema (Dropsy) 01/2022 - 04/2014
2	Osteoarthritis 01/2022 - 01/2016
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 06/2018
2	Leukemia 11/2016 - 01/2007
2	Body Weight (Weight, Body) 08/2012 - 10/2011
2	Stomach Neoplasms (Stomach Cancer) 01/2007 - 09/2003
1	Fatigue 01/2022
1	Anemia 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Infections 01/2022
1	Triple Negative Breast Neoplasms 04/2021
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Bone Diseases (Bone Disease) 01/2016
1	Hypoxia (Hypoxemia) 11/2015

Drug/Important Bio-Agent (IBA)

6	CateninsIBA 09/2020 - 08/2012
6	ErbB Receptors (EGF Receptor)IBA 04/2020 - 10/2011
5	DiterpenesIBA 09/2020 - 10/2011
5	Tyrosine Kinase InhibitorsIBA 04/2020 - 04/2015
4	Gefitinib (Iressa)FDA Link 04/2020 - 11/2012
4	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 12/2005
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2012 - 12/2005
4	Matrix Metalloproteinases (MMPs)IBA 08/2012 - 12/2005
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2011
3	MicroRNAs (MicroRNA)IBA 09/2018 - 01/2017
3	Biological ProductsIBA 03/2018 - 05/2006
3	mezereinIBA 01/2015 - 10/2011
3	StilbenesIBA 05/2013 - 01/2011
3	lissamine rhodamine B (sulforhodamine B)IBA 04/2008 - 01/2007
3	ZincIBA 05/2006 - 12/2005
3	Messenger RNA (mRNA)IBA 05/2006 - 12/2005
3	Peptide Hydrolases (Proteases)FDA Link 05/2006 - 12/2005
3	indoleIBA 12/2005 - 09/2003
2	CarrageenanIBA 01/2022 - 04/2014
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2020 - 11/2012
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 09/2018 - 03/2018
2	LigandsIBA 03/2018 - 10/2011
2	Pharmaceutical PreparationsIBA 01/2017 - 11/2012
2	SaponinsIBA 04/2016 - 04/2011
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2016 - 08/2012
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 06/2014
2	EnzymesIBA 01/2016 - 01/2011
2	LignansIBA 12/2015 - 10/2013
2	TCF Transcription FactorsIBA 07/2013 - 08/2012
2	pinosylvinIBA 05/2013 - 08/2012
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 04/2008 - 02/2007
2	Tissue Inhibitor of Metalloproteinase-2IBA 05/2006 - 12/2005
2	Tissue Inhibitor of MetalloproteinasesIBA 12/2005 - 12/2005
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 04/2021
1	pulvomycinIBA 04/2021
1	Docetaxel (Taxotere)FDA Link 04/2021
1	nodosinIBA 09/2020
1	Kaurane DiterpenesIBA 09/2020
1	imidazoleIBA 01/2020
1	topsentin AIBA 01/2020
1	AlkaloidsIBA 01/2020
1	topsentinIBA 01/2020
1	Furocoumarins (Furanocoumarins)IBA 01/2020
1	oxypeucadaninIBA 01/2020
1	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 09/2018
1	LDN 193189IBA 09/2018
1	Bone Morphogenetic Protein ReceptorsIBA 09/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2018
1	AMP-Activated Protein KinasesIBA 06/2018
1	dihydrotanshinone IIBA 06/2018
1	Mitogen-Activated Protein KinasesIBA 06/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	esculetinIBA 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	5- (1- (glucopyranosyloxymethyl)ethenyl)- 2- methyl- 2- cyclohexen- 1- oneIBA 04/2016
1	safranine T (safranin)IBA 01/2016
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2016
1	Hematoxylin (Haematoxylon)IBA 01/2016
1	shinbaroIBA 01/2016
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2016
1	Fast GreenIBA 01/2016
1	Dinoprostone (PGE2)FDA Link 01/2016
1	CytokinesIBA 01/2016
1	Iodoacetic AcidIBA 01/2016
1	Collagen Type II (Type II Collagen)IBA 01/2016
1	AntibodiesIBA 01/2016
1	Checkpoint Kinase 2IBA 12/2015
1	americanin AIBA 12/2015
1	Checkpoint Kinase 1IBA 12/2015
1	Cytotoxins (Cytolysins)IBA 11/2015
1	Oxygen (Dioxygen)IBA 11/2015
1	salternamide AIBA 11/2015

Therapy/Procedure

2	Oral Administration 04/2014 - 10/2011
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022
1	Chemoprevention 03/2018
1	Drug Therapy (Chemotherapy) 01/2017
1	Therapeutics 01/2016